April 18, 2017
DermTech partners with two pharmaceutical companies
DermTech, Inc., a player in non-invasive molecular dermatology, has entered into two collaborations with multi-national pharmaceutical companies,
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 17, 2017
OncoMed’s lung cancer drug fails mid-stage study, shares tumble
OncoMed Pharmaceuticals Inc said on Monday its experimental lung cancer drug failed a mid-stage study, sending its shares tumbling 30 percent in premarket trading.
April 17, 2017
Roche haemophilia drug shows good result in treating children
Roche has reported interim results from the phase III HAVEN 2 study evaluating emicizumab prophylaxis in children less than 12 years of age with haemophilia A and inhibitors to factor VIII.
April 14, 2017
China’s Biostar Pharmaceuticals reports $5.7M loss in 2016
Biostar Pharmaceuticals, a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, has reported its financial results for the year ended December 31, 2016.
April 13, 2017
Sensorion welcomes new CEO
Sensorion, a biotech company specializing in the treatment of inner ear diseases, has appointed Nawal Ouzren as the Company’s new CEO.
April 13, 2017
Erytech raises €70.5M in a private placement to U.S. and European investors
Erytech Pharma, the French clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, has purchased ordinary shares of the company in a private placement reserved for a specified category of investors (the “Reserved Offering”).
April 13, 2017
Destiny Pharma welcomes new CEO
Destiny Pharma, a clinical stage biotech company focused on the development of new anti-microbial drugs, has appointed Neil Clark as Chief Executive Officer (CEO) and member of the Board of Directors, effective immediately.
April 13, 2017
Plasticell gets near £920K for making red blood cells from pluripotent stem cells
Innovative UK poured almost a million pounds to a developer of cell therapies including hematopoietic cell replacement therapies, Plasticell.
April 13, 2017
Diplomat in a deal with Corizon Health
Diplomat Pharmacy and Corizon Health have entered into three-year agreement according to which Diplomat will provide pharmacy services and dispense limited-distribution specialty drugs for Corizon Health’s clients and support its in-house mail-order pharmacy, PharmaCorr
April 12, 2017
Respira Therapeutics, United Therapeutics Corporation join to fight pulmonary hypertension
Respira Therapeutics, a privately held pharmaceutical company developing innovative inhaled therapies to treat pulmonary hypertension and other pulmonary diseases, has entered into a strategic collaboration with United Therapeutics Corporation for the development and exclusive license of Respira’s inhaled drug-device product, RT234, for pulmonary hypertension indications in North America.